From Raw Patient Data to Governed, Research-Ready Cohorts

In an earlier post, we wrote about why research teams outgrow legacy environments, and why the foundation has to be redesigned rather than simply rehosted. A governed, de-identified, well-organized data platform makes future analytics and AI realistic.

This post is about what comes next. Our Medical Research Platform is now an approved Databricks Brickbuilder Solution. It takes that foundation further, from data that is safe to use to data that researchers can actually find, explore and turn into cohorts across every modality.

The Next Bottleneck: Finding the Right Patients

Once sensitive data is governed and de-identified, a new constraint shows up. The data is safe, but it is not yet easy to use.

Much of the most valuable research data is unstructured. DICOM imaging studies, clinical notes, contracts and provider records rarely fit neatly into tables. Organizations can be sitting on hundreds of terabytes of it. Without a way to understand what is inside those files, researchers cannot search them, and cohort building falls back to manual requests, data engineering queues and spreadsheets passed between teams.

The question research leaders ask us has shifted. It is no longer only “Is our data protected?” It is “How quickly can a researcher go from a study idea to the right set of patients, without compromising that protection?”

What the Platform Delivers

The Medical Research Platform is an end-to-end research environment on the Databricks Lakehouse, delivered as a data-as-a-service model. It brings imaging, clinical and provider data together in one governed place and turns it into research-ready cohorts.

It starts with ingestion at scale. Large volumes of multimodal data, including a migration path for legacy archives, move onto the lakehouse with file-level auditing, so every record in a cohort can be traced back to its source.

Next, the platform makes unstructured data understandable. Clinical language in notes and documents is turned into searchable metadata, and imaging is processed with industry-standard tools, including MONAI by NVIDIA and the Databricks Pixels accelerator, so studies can be analyzed and stripped of identifying details before they reach researchers.

Governance is built in, not bolted on. Standardized de-identification and access controls live in Unity Catalog alongside the data, giving compliance teams one consistent, auditable record.

Finally, discovery becomes conversational. With Databricks Genie, researchers can explore and tag cohorts by asking questions in plain language, across every modality, and only within the de-identified data they are approved to see. This is the step that closes the loop our earlier post pointed toward: a governed foundation that researchers can now use directly.

Where It Matters Across Healthcare and Life Sciences

The pressures are shared across the sector, but the payoff looks different depending on who holds the data.

Academic medical centers and health systems. Decades of clinical and imaging archives become a governed research asset instead of a compliance liability, so internal research programs can move without restarting the approval and extraction cycle for every study.
Pharmaceutical and biotech companies. Feasibility and cohort selection depend on finding the right patients quickly in real-world data. Conversational discovery across modalities shortens that early, often frustrating phase of study design.
Research institutes. Collaboration requires every partner to trust how data was prepared. Standardized, auditable de-identification gives a consistent basis for sharing research-ready datasets.
Imaging and diagnostics providers. Large DICOM collections are the raw material for medical imaging AI. Redaction and metadata built into the pipeline make those collections usable for model development without manual scrubbing.
Payers and provider networks. Combining provider and clinical data opens up outcomes research, as long as identities stay protected. Governance in Unity Catalog keeps that line clear.

The Business Value

The value shows up in speed, trust and reach.

Speed comes from removing the restart cost of every new study. When ingestion, metadata, de-identification and discovery run on one governed platform, the path from research question to usable cohort gets shorter, and researchers spend less time waiting on data teams.

Trust comes from controls that regulators, IRBs and data partners can verify. File-level lineage and standardized de-identification in Unity Catalog mean an audit question is answered with evidence rather than reconstruction.

Reach comes from putting unstructured data to work. Imaging and free-text notes stop being archives that only specialists can access and become part of the searchable research record.

And because the model is data as a service, each new study reuses the same governed pipeline. The platform gets more valuable with use rather than more expensive.

Final Thoughts

Modernizing a research data platform starts with a governed foundation. The organizations that pull ahead are the ones that take the next step and put that foundation directly in researchers’ hands.

The Medical Research Platform brings secure ingestion, built-in privacy controls and conversational discovery together on Databricks, so sensitive, multimodal data can become research-ready cohorts without trading speed for control.

For more information or a live demo of our Medical Research Platform, contact us.